quinuclidines has been researched along with Cancer of Pancreas in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, SL; Cocco, L; Duda, P; Gizak, A; Lombardi, P; Martelli, AM; McCubrey, JA; Ratti, S; Steelman, LS | 1 |
| Abrams, SL; Akula, SM; Cervello, M; Cocco, L; Duda, P; Emma, MR; Follo, ML; Gizak, A; Martelli, AM; McCubrey, JA; Montalto, G; Rakus, D; Ratti, S; Steelman, LS | 1 |
| Ausseil, F; Cordelier, P; Dedieu, L; Ducommun, B; Dufau, I; Frongia, C; Sicard, F; Valette, A | 1 |
3 other study(ies) available for quinuclidines and Cancer of Pancreas
| Article | Year |
|---|---|
APR-246-The Mutant TP53 Reactivator-Increases the Effectiveness of Berberine and Modified Berberines to Inhibit the Proliferation of Pancreatic Cancer Cells.
Topics: Berberine; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Proliferation; Humans; Pancreatic Neoplasms; Quinuclidines; Tumor Suppressor Protein p53 | 2022 |
Effects of the Mutant TP53 Reactivator APR-246 on Therapeutic Sensitivity of Pancreatic Cancer Cells in the Presence and Absence of WT-TP53.
Topics: Adenocarcinoma; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Humans; Pancreatic Neoplasms; Quinuclidines; Tumor Suppressor Protein p53 | 2022 |
Multicellular tumor spheroid model to evaluate spatio-temporal dynamics effect of chemotherapeutics: application to the gemcitabine/CHK1 inhibitor combination in pancreatic cancer.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Pancreatic Ductal; Cell Proliferation; Deoxycytidine; DNA Damage; Drug Resistance, Neoplasm; Gemcitabine; Humans; Models, Biological; Pancreatic Neoplasms; Protein Kinase Inhibitors; Quinolines; Quinuclidines; Spheroids, Cellular; Tumor Cells, Cultured; Tumor Microenvironment | 2012 |